AIL
PFE icon

AGF Investments LLC’s Pfizer PFE Stock Holding History

AGF Investments LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.58M Buy
36,041
+16,017
+80% +$778K 0.14% 87
2022
Q2 		$1.05M Buy
20,024
+12,492
+166% +$637K 0.1% 41
2022
Q1 		$390K Sell
7,532
-610
-7% -$31.6K 0.03% 263
2021
Q4 		$481K Sell
8,142
-1,568
-16% -$77.7K 0.04% 247
2021
Q3 		$418K Sell
9,710
-9,530
-50% -$422K 0.04% 248
2021
Q2 		$753K Sell
19,240
-461
-2% -$17.9K 0.08% 60
2021
Q1 		$714K Sell
19,701
-4,464
-18% -$158K 0.09% 79
2020
Q4 		$890K Sell
24,165
-8,281
-26% -$304K 0.11% 75
2020
Q3 		$1.13M Sell
32,446
-51,670
-61% -$1.81M 0.13% 217
2020
Q2 		$2.61M Sell
84,116
-7,682
-8% -$261K 0.27% 43
2020
Q1 		$2.84M Sell
91,798
-28,692
-24% -$978K 0.37% 26
2019
Q4 		$4.48M Sell
120,490
-104,176
-46% -$3.71M 0.83% 13
2019
Q3 		$7.66M Sell
224,666
-54,351
-19% -$1.98M 1.8% 5
2019
Q2 		$11.5M Sell
279,017
-23,379
-8% -$928K 2.39% 4
2019
Q1 		$12.2M Sell
302,396
-239,550
-44% -$9.59M 2.73% 3
2018
Q4 		$22.4M Buy
541,946
+16,447
+3% +$683K 3.1% 1
2018
Q3 		$22M Sell
525,499
-100,279
-16% -$3.86M 2.79% 3
2018
Q2 		$21.5K Buy
625,778
+110,239
+21% +$3.77M 2.47% 3
2018
Q1 		$17.4M Buy
515,539
+43,343
+9% +$1.49M 2.93% 5
2017
Q4 		$16.2M Buy
472,196
+88,297
+23% +$3.01M 2.8% 7
2017
Q3 		$13M Sell
383,899
-5,705
-1% -$183K 2.88% 6
2017
Q2 		$12.4M Buy
389,604
+25,536
+7% +$805K 2.84% 8
2017
Q1 		$11.8M Buy
364,068
+19,902
+6% +$627K 2.97% 8
2016
Q4 		$10.6M Buy
+344,166
New +$10.5M 2.8% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AGF Investments LLC's PFE Position: Q3 2022 in Review

AGF Investments LLC increased its Pfizer (PFE) stake by 80% in Q3 2022, buying an estimated $778K and bringing the position to 36,041 shares worth $1.58M. The position accounts for 0.14% of the portfolio, ranked #87.

AGF Investments LLC first reported a position in PFE in Q4 2016 and has held it in 24 quarters since. The position peaked at $22.4M in Q4 2018. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • AGF Investments LLC held 36,041 shares of Pfizer worth $1.58M as of Q3 2022.
  • AGF Investments LLC bought 16,017 Pfizer shares in Q3 2022, an estimated $778K.
  • Pfizer made up 0.14% of AGF Investments LLC's portfolio in Q3 2022, its #87 holding.
  • AGF Investments LLC first reported a position in Pfizer in Q4 2016 and has held it in 24 quarters since.
  • AGF Investments LLC's Pfizer position peaked at $22.4M in Q4 2018.
  • 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.